Ajay Gopal

Has grant

University of Washington

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Molecularly Targeted Therapy for Lymphoma

Open Date: 2014-07-18

Close Date: 2019-06-30

Grant: Close

Proapoptotic Therapy for B-cell Non Hodgkin's Lymphoma

Open Date: 2006-02-01

Close Date: 2010-01-31

Grant: Close

OPTIMIZING RADIOIMMUNOTHERAPY FOR NON HODGKIN'S LYMPHOMA

Open Date: 2000-08-21

Close Date: 2007-07-31

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2021

Year:

UNITED STATES

View details

Phuong Vo

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

Deborah Stephens

Assistant Professor

Huntsman Cancer Institute

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ajay Gopal

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (10)

Ibrutinib and Venetoclax in Relapsed and Refractory Follicular Lymphoma

Clinical Relevance of Intensive Laboratory Monitoring With Standard Venetoclax Ramp-Up for Chronic Lymphocytic Leukemia: A Real-World Experience

Remission Assessment by Circulating Tumor DNA in Large B-cell Lymphoma

Nivolumab plus relatlimab for patients with relapsed or progressed B-cell malignancies in RELATIVITY-022

Targeted Radiation Delivery before Haploidentical HCT for High-risk Leukemia or MDS Patients Yields Long-term Survivors

Hypertension treatment for patients receiving ibrutinib: a multicenter retrospective study

Pembrolizumab With R-CHOP in Previously Untreated DLBCL: Sustained, High Efficacy, and Safety With Long-Term Follow-Up

A Phase I Trial of Talazoparib in Patients with Advanced Hematologic Malignancies

Umbralisib: Walking the Tightrope of PI3K Inhibition in Indolent NHL

Axicabtagene ciloleucel for relapsed or refractory lymphoma after prior treatment with a different CD19-directed CAR T-cell therapy

Collaborators (7)

Ayushi Chauhan

Edus Warren

David Kurtz

Victor Chow

Mark Roschewski

Phuong Vo

Deborah Stephens

Make your next move.